Provenance Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-328
| Closed | -$26.6K | – | 552 |
|
|
2025
Q1 | $26.6K | Sell |
328
-2,100
| -86% | -$170K | ﹤0.01% | 258 |
|
|
2024
Q4 | $219K | Hold |
2,428
| – | – | 0.03% | 140 |
|
|
2024
Q3 | $240K | Hold |
2,428
| – | – | 0.03% | 142 |
|
|
2024
Q2 | $225K | Sell |
2,428
-226
| -9% | -$21K | 0.03% | 132 |
|
|
2024
Q1 | $252K | Hold |
2,654
| – | – | 0.04% | 129 |
|
|
2023
Q4 | $237K | Buy |
2,654
+100
| +4% | +$8.93K | 0.03% | 119 |
|
|
2023
Q3 | $186K | Buy |
+2,554
| New | +$186K | 0.03% | 120 |
|